AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Mural Oncology PLC Director's Dealing 2025

Sep 2, 2025

14932_dirs_2025-09-02_0c95cf54-b7f3-4562-8e0c-9878f6c7205e.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Mural Oncology plc (MURA US)
CIK: 0001971543
Period of Report: 2025-08-22

Reporting Person: Trium Capital LLP (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Mural Oncology Plc - MURA US EQUITY	1760097	Direct